VS
Vansh Sanjay Jain
About Vansh Sanjay Jain
Data last updated:
Vansh Sanjay Jain is a Director at Shri Jinvar Marketing Private Limited (since 2024) and Director at Wellogen Pharma Private Limited (since 2022). The companies operate in FMCG and Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹9.03 Cr; the largest is Shri Jinvar Marketing Private Limited at ₹6.95 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Shri Jinvar Marketing Private Limited U51101MH2013PTC248231 | Director | 05 Dec 2024 | 2013 | ₹6.95 Cr (FY 2025) | Active |
| Wellogen Pharma Private Limited U24299GJ2021PTC121391 | Director | 08 Dec 2022 | 2021 | ₹2.08 Cr (FY 2023) | Active |
Board colleagues of Vansh Sanjay Jain
| Name | DIN | Company | Designation |
|---|---|---|---|
| Sanjay Kesharimalji Jain | 07204043 | Shri Jinvar Marketing Private Limited | Director |
| Vikas Kesharimalji Jain | 06654430 | Shri Jinvar Marketing Private Limited | Director |
| Tarun Bhanwarlal Jain | 09835222 | Wellogen Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Vansh Sanjay Jain
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vansh Sanjay Jain
Vansh Sanjay Jain currently holds 2 directorships: Shri Jinvar Marketing Private Limited (Director, since 05 Dec 2024, revenue ₹6.95 Cr (FY 2025)); Wellogen Pharma Private Limited (Director, since 08 Dec 2022, revenue ₹2.08 Cr (FY 2023)).
Vansh Sanjay Jain was first appointed on 08 Dec 2022 as Director at Wellogen Pharma Private Limited. The most recent appointment on record is 05 Dec 2024 at Shri Jinvar Marketing Private Limited.
The 2 current companies of Vansh Sanjay Jain that report revenue have a combined latest revenue of ₹9.03 Cr: Shri Jinvar Marketing Private Limited ₹6.95 Cr (FY 2025); Wellogen Pharma Private Limited ₹2.08 Cr (FY 2023).
The current boards of Vansh Sanjay Jain's companies include Sanjay Kesharimalji Jain (Shri Jinvar Marketing Private Limited), Vikas Kesharimalji Jain (Shri Jinvar Marketing Private Limited), Tarun Bhanwarlal Jain (Wellogen Pharma Private Limited).